Clomid tablets, containing clomiphene citrate, is a non steroidal ovulatory stimulant.
Clomid is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy.
Male athletes also find Clomid interesting. In men using Clomid, the elevation in both follicle stimulating hormone and (primarily) luteinizing hormone will cause natural testosterone production to increase. This effect is especially beneficial to the athlete at the conclusion of a steroid cycle when endogenous testosterone levels are depressed. If endogenous testosterone levels are not brought beck to normal, a dramatic loss in size and strength is likely to occur once the anabolics have been removed. Clomid can play a crucial role in preventing this crash in athletic performance.
Clomid comes as a tablet containing 50 mg clomiphene citrate, to take by mouth. Impediments to achieving pregnancy must be excluded or adequately treated before beginning Clomid therapy.
The workup and treatment of candidates for Clomid therapy should be supervised by physicians experienced in management of gynecolic or endocrine disorders. Patients should be chosen for therapy with Clomid only after careful diagnostic evaluation.
Usually a woman will start Clomid to increase progesterone levels in her blood, and the dose may be increased gradually to obtain the optimum necessary to stimulate ovulation. If the period is regular, the woman will start taking Clomid three to five days into the monthly menstrual cycle and continue taking it for about five days.
Treatment of the selected patient should begin with a low dose, 50 mg daily for 5 days. The dose should be increased only in those patients who do not ovulate in response to cyclic 50 mg Clomid tablets.
For athletes using anabolic steroids, Clomid can normalize the testosterone level and the spermatogenesis (sperm development)within 10-14 days. For this reason Clomid is primarily taken after steroids are discontinued. At this time it is extremely important to bring the testosterone production to a normal level as quickly as possible so that the loss of strength and muscle mass is minimized.
50-100 mg./day seems is a sufficient dosage for athletes. Clomid is usually taken with fluids after meals. If several tablets are taken it is recomended that they be administered in equal doses distributed throughout the day. The duration of Clomid intake should not exceed 10 to 14 days. Most athlets begin with 100 mg./day taking one 50 mg. tablet every morning and evening after meals. After the fifth day the dosage is often reduced to only one 50 mg. tablet per day.
If you miss a dose, take it as soon as remembered if it is within an hour or so. If you do not remember until later, skip the missed dose and resume your usual dosing schedule. Do not "double-up" the dose to catch up.
Blurring or other visual symptoms such as spots or flashes may occasionally occur during therapy with Clomid. These visual symptoms increase in incidence with increasing total dose or therapy duration and generally disappear within a few days or weeks after Clomid is discontinued. These visual symptoms may render such activites as driving a car or operating machinery more hazardous than usual, particularly under conditions of variable lighting.
If experiencing visual symptom, treatment should be discontinued and complete ophthalmologic evaluation performed.
There is an increased chance of multiple pregnancy, including bilateral tubal pregnancy and coexisting tubal and intrauterine pregnancy, when conception occurs in relation to Clomid therapy.
It is not known whether Clomid is excreted in human milk. Caution should be exercised if Clomid is administered to a nursing woman. In some individuals, Clomid may reduce lactation.
Prolonged use of Clomid may increase the risk of a borderline or invasive ovarian tumor.
Possible side effects
Clomid at recommended dosages, is generally well tolerated. Adverse reactions usually have been mild and transient and most have disappeared promptly after treatment has been discontinued.
Side effects include ovarian enlargement, vasomotor flushes, abdominal-pelvic discomfort/distention/bloating, nausea and vomiting, breast discomfort, visual symptoms, headache and abnormal uterine bleeding.
If you notice other effects not listed above, contact your doctor.
If overdose of Clomid is suspected, contact your local poison control center or emergency room immediately. Toxic effects accompanying acute overdosage of Clomid have not been reported. Signs and symptoms of overdosage as a result of the use of more than the recommended dose during Clomid therapy include nausea, vomiting, vasomotor flushes, visual blurring, spots or flashes, scotomata, ovarian enlargement with pelvic or abdominal pain.
Keep Clomid in a tightly closed container and out of reach of children. Store Clomid at room temperature and away from excess heat and moisture (not in the bathroom).
The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, or other healthcare professional. It should not be construed to indicate that use of Clomid is safe, appropriate, or effective for you.
Consult your health care professional before you